1,536
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Liraglutide blocks the proliferation, migration and phenotypic switching of Homocysteine (Hcy)-induced vascular smooth muscle cells (VSMCs) by suppressing proprotein convertase subtilisin kexin9 (PCSK9)/ low-density lipoprotein receptor (LDLR)

, , , &
Pages 8057-8066 | Received 05 Jul 2021, Accepted 12 Sep 2021, Published online: 19 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sha Liao & Yahong Chen. (2024) The Role of Bioactive Small Molecules in COPD Pathogenesis. COPD: Journal of Chronic Obstructive Pulmonary Disease 21:1.
Read now
Chengyan Wu, Xulei Duan, Xuehui Wang & Libo Wang. (2023) Advances in the Role of Epigenetics in Homocysteine-Related Diseases. Epigenomics 15:15, pages 769-795.
Read now
Liying Wang, Lingling Zhou, Lihong Wang, Guifang Song & Lin Li. (2023) The diagnostic value of echocardiography combined with serum Hcy and PCSK9 in coronary heart disease. Biotechnology and Genetic Engineering Reviews 0:0, pages 1-10.
Read now
Xunjia Li, Chengxuan Liu, Ying Li, Weijian Xiong & Deyu Zuo. (2022) Inflammation promotes erythropoietin induced vascular calcification by activating p38 pathway. Bioengineered 13:3, pages 5277-5291.
Read now

Articles from other publishers (8)

Yi You, Naxin Zeng, Wengao Wu, Boyang Liu, Sheng Rong & Dong Xu. (2024) Association of Serum Homocysteine With Peripheral Arterial Disease in Patients Without Diabetes: A Study Based on National Health and Nutrition Examination Survey Database. The American Journal of Cardiology 218, pages 16-23.
Crossref
Jinghan Xu, Junrong Zuo, Chuyi Han, Tingting Li, Dongxia Jin, Fumei Zhao & Hongliang Cong. (2023) Proprotein convertase subtilisin/kexin 9 inhibitor downregulates microRNA-130a-3p expression in hepatocytes to alleviates atherosclerosis progression. Naunyn-Schmiedeberg's Archives of Pharmacology 397:3, pages 1727-1736.
Crossref
Ae Sin LeeYiseul KimHaeng Jeon HurSang-Hee LeeMi Jeong Sung. (2023) Chrysanthemum coronarium L. Extract Attenuates Homocysteine-Induced Vascular Inflammation in Vascular Smooth Muscle Cells . Journal of Medicinal Food 26:12, pages 869-876.
Crossref
Jia-ni Xu, Ting-ting Wang, Hong Shu, Shun-yi Shi, Li-chan Tao & Jian-Jun Li. (2023) Insight into the role of PCSK9 in glucose metabolism. Clinica Chimica Acta 547, pages 117444.
Crossref
Zhenxian Li, Haimei Zhu, Hao Liu, Dayue Liu, Jianhe Liu, Jiazheng Jiang, Yi Zhang, Zhang Qin, Yijia Xu, Yuan Peng, Bin Liu & Yun Long. (2023) Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy. Journal of Nanobiotechnology 21:1.
Crossref
Zorislava Bajic, Tanja Sobot, Snezana Uletilovic, Nebojsa Mandic-Kovacevic, Tanja Cvjetkovic, Ugljesa Malicevic, Djordje Djukanovic, Mladen Duran, Nikolina Vesic, Sanja Avram, Sanja Jovicic, Maja Katana, Amela Matavulj, Nenad Ponorac, Dragan M Djuric, Milos P Stojiljkovic & Ranko Skrbić. (2023) Cardioprotective effects of liraglutide pretreatment on isoprenaline-induced myocardial injury in rats. Canadian Journal of Physiology and Pharmacology 101:5, pages 258-267.
Crossref
Qinchao Wu, Daisong Li, Chao Huang, Guoliang Zhang, Zheng Wang, Jiane Liu, Haichu Yu, Bingxue Song, Ning Zhang, Bing Li & Xianming Chu. (2022) Glucose control independent mechanisms involved in the cardiovascular benefits of glucagon-like peptide-1 receptor agonists. Biomedicine & Pharmacotherapy 153, pages 113517.
Crossref
Shengxiong Pu, Chaojun Jia, Zhimin Li & Yunhua Zang. (2022) Protective Mechanism of Proprotein Convertase Subtilisin-Like Kexin Type 9 Inhibitor on Rats with Middle Cerebral Artery Occlusion-Induced Cerebral Ischemic Infarction. Computational Intelligence and Neuroscience 2022, pages 1-8.
Crossref